Importantly, in this process, sEVs carry ApoC1 from ccRCC cells to vascular endothelial cells and induce EMT via STAT3 activation, consequently boosting the proliferative, invasive, and metastatic abilities of ccRCC cells. Here, APOC1 is linked to nonpapillary renal cell carcinoma.